FindTrial
Sign In

Utilizing imaging data to investigate the relationship between different PI-RADS regions and patient biopsy results, postoperative Gleason scores, and prognostic indicators.

Utilizing imaging data to investigate the relationship between different PI-RADS regions and patient biopsy results, postoperative Gleason scores, and prognostic indicators.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400088181
Enrollment
Unknown
Registered
2024-08-13
Start date
2024-01-20
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

prostate cancer:None

Sponsors

Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Inclusion criteria: All patients diagnosed with prostate stones who underwent MRI imaging examination between February 20, 2018, and March 20, 2023. Complete medical records and imaging data are required for all patients.

Exclusion criteria

Exclusion criteria: Exclusion criteria: Patients with contraindications for MRI or those unable to undergo MRI examinations; patients with incomplete medical records or imaging data.

Design outcomes

Primary

MeasureTime frame
Size of PI-RADS scoring area;Location of PI-RADS scoring area;Patient biopsy results;Postoperative Gleason score;Postoperative PSA level;—

Countries

China

Contacts

Public ContactFei Gao

Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

gaofei@hospital.cqmu.edu.cn+86 136 0835 6433

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026